HomeHAVLF • OTCMKTS
add
HAVN Life Sciences Inc
Previous close
$0.0010
Market cap
859.38K CAD
Avg Volume
2.59K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2023info | Y/Y change |
|---|---|---|
Revenue | -12.06K | — |
Operating expense | 563.42K | — |
Net income | -691.54K | — |
Net profit margin | 5.73K | — |
Earnings per share | — | — |
EBITDA | -646.64K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.99K | — |
Total assets | 1.38M | — |
Total liabilities | 540.44K | — |
Total equity | 837.82K | — |
Shares outstanding | 14.74M | — |
Price to book | 0.02 | — |
Return on assets | -108.13% | — |
Return on capital | -153.06% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2023info | Y/Y change |
|---|---|---|
Net income | -691.54K | — |
Cash from operations | 289.12K | — |
Cash from investing | — | — |
Cash from financing | -283.77K | — |
Net change in cash | 5.36K | — |
Free cash flow | 45.42K | — |
About
CEO
Founded
2020
Headquarters
Website
Employees
6
